@inproceedings{inproceedings, title  = {{A phase II single-arm study of the FGFR inhibitor pemigatinib in patients with metastatic colorectal cancer (mCRC) harboring FGF/FGFR alterations.}},

 url = {{}},

 year = {{2023}},

 month = {{1}},

 author = {{Ciombor KK and Zemla TJ and Hubbard JM and Jia J and Gbolahan OB and Sousa A and Wilson L and Waechter B and Ou F-S and Nixon AB and Bekaii-Saab TS}},

 volume = {{41}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 pages = {{139-139}},

 note = {{Accessed on 2024/12/22}}}